I have discussed partnership and investment opportunities as ways to help businesses grow, with different posts covering Fixderma’s proposed Lotus partnership and my investment in Rimigo.
I said Fixderma has a solid understanding of the trajectory of dermaceutical business.
I said Fixderma has a clear understanding of their customer base.
I described Lotus as a strategic partner for Fixderma.
I said Lotus as a strategic partner would definitely help Fixderma to expand their brand reach, add value to the company and create brand trust.
The Lotus post expressed anticipated benefits of a proposed strategic partnership; it did not report that the partnership had been finalized or describe its terms.
I know when someone from a tier 2 or tier 3 city books an international trip, it's not a casual decision.
I said it's a 12–14 month savings cycle that needs full family consensus and a lot of pressure to do it right.
I said that without a travel agent, planning it quickly becomes a 40-tab nightmare.
- I described the fragmented trip-planning process: flights on Skyscanner, hotels on MakeMyTrip, activities from Reddit threads, and advice from a cousin who went to that country once.
I said most travel platforms are built for metro travelers who treat travel casually.
I said outbound tourism from these cities is growing at nearly 2x the rate of metros.
I said Rimigo had already organised 120 vacations in beta, with 50 completed, and almost zero paid acquisition.
I said most of Rimigo’s growth came through word of mouth.
I said Rimigo’s beta traction usually tells me the product is solving a real problem for people.
I said Shubham, Sahil, and Aditya are all second-time founders.
I said the founders’ previous company was acquired by PhonePe before any of them turned 27, delivering roughly 30x to early investors.
When I evaluate repeat founders, I’m looking at what they learned about distribution, about unit economics under pressure, about when to scale and when not to.
I said second-time founders usually have better pattern recognition about where companies actually die.
I said that when you combine a large underserved market, early organic traction, and founders who have already built and exited once, that’s the kind of bet you want to be early on.
I said that’s why I invested in them this season.
My stated Rimigo investment rationale combined a large underserved market, early organic traction, and experienced founders; the post did not disclose my investment amount, valuation, or the name of the founders’ previous company.
Related: skin health and wellbeing, building sustainable businesses, founder insights and resources